跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,059 条关于
“OX40 receptor”
全部
12,059
临床试验
5,756
药物
1,338
机构
30
资讯
4,935
去年
FDA Clears IND Application for Novel Monoclonal Antibody OX40 Antagonist for Atopic Dermatitis
去年
Kyowa Kirin to Present Phase 3 Rocatinlimab Results for Atopic Dermatitis at EADV 2025
去年
Rocatinlimab Shows Promise in Phase 3 Trial for Moderate to Severe Atopic Dermatitis
去年
Astria Therapeutics' STAR-0310 Receives FDA Clearance for Atopic Dermatitis Trial
7个月前
Kyowa Kirin Regains Control of Rocatinlimab Development Following Amgen Partnership Termination
去年
Inmagene Initiates Phase 2b Trial of IMG-007 Anti-OX40 Antibody for Moderate-to-Severe Atopic Dermatitis
6个月前
ImageneBio Secures $30M Funding to Advance OX40 Antagonist IMG-007 Through Phase 2 Trials
去年
Rocatinlimab Shows Significant SCORAD Improvement in Atopic Dermatitis Phase 2b Trial
去年
Rocatinlimab Shows Promising Results in Phase 3 Trial for Moderate to Severe Atopic Dermatitis
8年前
Stanford Researchers Develop Injectable Cancer 'Vaccine' That Eliminates Tumors in Mice
第 1 页,共 494 页
上一页
下一页